Trade Summary

5 days ago, Forminard Elizabeth, serving as EVP, Chief Legal Officer at JOHNSON & JOHNSON (JNJ), sold 15,918 shares at $257.00 per share, for a total transaction value of $4,090,959.69. Following this transaction, Forminard Elizabeth now holds 16,994 shares of JNJ.

This sale represents a 48.37% decrease in Forminard Elizabeth's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 5:44 PM ET, 1 day after the trade was made.

JOHNSON & JOHNSON operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.